Mean predicted Δ SHS for patients in remission, LDA, MDA and HDA
Remission | LDA | MDA | HDA | |
---|---|---|---|---|
Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | |
DAS | 3.49 (−0.06 to 7.04) | 5.50 (2.35 to 8.66) | 7.34 (4.09 to 10.60) | 11.70 (7.39 to 16.01) |
DAS CRP | 4.08 (0.95 to 7.21) | 5.44 (2.34 to 8.55) | 6.69 (3.58 to 9.81) | 11.72 (7.09 to 16.35) |
DAS28 | 3.57 (0.12 to 7.02) | 4.61 (1.43 to 7.79) | 6.88 (3.77 to 9.98) | 10.83 (6.83 to 14.83) |
DAS28 CRP | 3.54 (−0.03 to 7.10) | 5.54 (2.34 to 8.74) | 8.05 (4.80 to 11.30) | 13.18 (8.51 to 17.84) |
SDAI | 4.01 (0.76 to 7.26) | 4.67 (1.37 to 7.97) | 7.39 (4.16 to 10.61) | 11.48 (7.25 to 15.71) |
CDAI | 3.85 (0.64 to 7.06) | 4.66 (1.41 to 7.91) | 7.40 (4.18 to 10.61) | 10.95 (6.89 to 15.00) |
DAS 0–1 | 3.41 (−0.05 to 6.87) | 5.45 (2.33 to 8.57) | 7.21 (4.01 to 10.42) | 12.66 (8.21 to 17.12) |
DAS TJC53 | 3.54 (0.17 to 6.90) | 4.78 (1.45 to 8.11) | 6.89 (3.69 to 10.08) | 9.92 (6.02 to 13.82) |
DAS TJC44 | 3.64 (0.28 to 7.00) | 4.92 (1.60 to 8.24) | 7.16 (3.96 to 10.36) | 10.24 (6.25 to 14.23) |
Covariates and factors appearing in the model are fixed at the following values: previous SHS 10.3; year 2.8; age 53.8; treatment group 1; anti-CCP positive patients; female gender.
CDAI, Clinical Disease Activity Index; CRP, C reactive protein; DAS, Disease Activity Score; DAS 0–1, Disease Activity Score with RAI 0–1; DAS28, Disease Activity Score in 28 joints; HDA, high disease activity; LDA, low disease activity; MDA, moderate disease activity; SDAI, Simplified Disease Activity Index; SHS, Sharp/van der Heijde score; TJC44, tender joint count 44 joints; TJC53, tender joint count 53 joints.